Speaker profile

Matthias Frech

Director, Molecular Interactions and Biophysics
Merck KGaA

Matthias is responsible for the Molecular Interaction and Biophysics department. The group is conducting molecular interaction studies and protein crystallographic work, to get insight into the mode of action with a variety of biophysical methods. Bridging high throughput screening and medicinal chemistry with structural and mechanistic data to support the optimization of potential drug like molecules.

Prior to that, Matthias was responsible for a protein chemistry group working with different biophysical interaction methods combined with the protein purification and analysis for structural studies and screening. Matthias had a post-doctoral position at the Friedrich Miescher Institute, part of the Novartis Research organisation, focusing on protein kinases and their biochemical characterization. As EMBO fellow, Matthias worked in the technology park of Sophia Antipolis nearby Nice/ France, on nucleotide exchange factors and adaptor proteins in the p21ras signaling pathway. He carried out doctoral work in the Department of Biophysics at the Max Plank Institute in Heidelberg focusing on structure and molecular interaction studies of small p21ras like proteins.

Agenda sessions

Day 2

November 14, 2019

  • The Innovation Lab

    • The Innovation Lab
      This stream will focus on bringing the Lab of the Future to life. Enabling collaborations and partnerships, running innovation hubs and creating the physical and business environments for innovation.
    • 2:30 pm
      Innovations in Lab technology aiding biophysic based drug discovery